Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice

Acta Physiologica Sinica

Volumn 55, Issue 5, 2003, Pages 571-576

  Jiang, Hong ^a   Qian, Zhong Ming ^b   Xie, Jun Xia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b NONE

Author keywords

Divalent metal transporter 1; Iron; Parkinson's disease; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; IRON; ISOENZYME; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; GENE EXPRESSION; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CATION TRANSPORT PROTEINS; DOPAMINE; IRON; IRON-BINDING PROTEINS; MICE; MICE, INBRED C57BL; PARKINSONIAN DISORDERS; PROTEIN ISOFORMS; SUBSTANTIA NIGRA; TRANSFERRIN;

EID: 0242712032     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rouault TA. Iron on the brain. Nature Genetics 2001;28 (4):299-300.
2. Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation of iron in the brain in neurodegenerative disorders. Brain Res Rev 1998;27(3): 257-267.
3. Qian ZM, Shen X. Brain iron transport and neurodegeneration. Trends Mol Med 2001;7(3):103-108.
4. Gruenheid S, Cellier M, Vidal S, Gros P. Identification and characterization of a second mouse Nramp gene. Genomics 1995;25(2):514-525.
5. Fleming MD, Trenor CC 3rd, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 1997;16(4):383-386.
6. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388(6641): 482-488.
7. Jiang H, Chen WF, Xie JX. Rlationship between dopamine and iron contents in the brain of Parkinsonian rats. Acta Physiol Sin 2001;53(5):334-338 (Chinese, English abstract).
8. Schmidt N, Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J Neural Transm 2001;108:1263-1282.
9. Russ H, Staust K, Martel F, Gliese M, Schomig E. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 1996;8:1256-1264.
10. Blum D, Torch S, Lambeng N, Nissou MF, Benabid AL, Sadoul R, Verna JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001;65:135-172.
11. Mochizuki H, Imai H, Endo K, Yokomizo K, Murata Y, Hattori N, Mizuno Y. Iron accumulation in the substantia nigra of 1-methy-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci Lett 1994;68:251-253.
12. Yantiri F, Andersen JK. The role of iron in Parkinson's disease and 1-methy-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity. IUBMB Life 1999;8:139-141.
13. He Y, Lee T, Leong SK. Time-course and localization of transferring receptor expression in the substantia nigra of 6-hydroxydopamine-induced Parkinsonian rats. Neuroscience 1999;91(2):579-585.
14. hang L, Lee T, Wang Y, Soong TW. Heterologous expression, functional characterization and localization of two isoforms of the monkey iron transporter Nramp2. J Biochem 2000;349:289-297.